Invest Securities has reiterated its 'buy' rating on Assystem, with the target price raised once again from €54 to €58, believing the momentum to be 'buoyant', even though the share price has risen by 39% since mid-October, with an acceleration at the end of January.

Last night's publication demonstrates once again the development potential of our nuclear activities, and momentum remains positive in the short term, with the exceptional dividend linked to the sale of Framatome likely to be appreciated", the analyst believes.

All that remains now is to sell Expleo to definitively put an end to its holding status and the associated discount, in order to focus on the development potential linked to the restart of the nuclear cycle", he continues.

Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.